Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
DVAX earnings call for the period ending December 31, 2023.
Stay updated with breaking news from Robert Janssen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DVAX earnings call for the period ending December 31, 2023.
Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) CMO Robert Janssen sold 1,500 shares of the stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $15.00, for a total value of $22,500.00. Following the completion of the transaction, the chief marketing officer now directly owns […]
Mizuho Markets Americas LLC reduced its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 9.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 682,707 shares of the biopharmaceutical company’s stock after selling 74,200 shares during the period. Dynavax […]
Royce & Associates LP raised its position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 0.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 442,257 shares of the biopharmaceutical company’s stock after purchasing an additional 3,071 shares during the period. Royce & Associates LP owned 0.35% […]
Arizona State Retirement System lifted its position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 2.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,085 shares of the biopharmaceutical company’s stock after acquiring an additional 966 shares during the […]